MabGenesis
Latest round
- Seed
Last raised
- Jun 2020
Total raised
- $2.6M
Investors
- 4
About MabGenesis
Based in Japan, MabGenesis Inc.Founded in 2019 in Yokohama-shi, Japan, MabGenesis Inc. focuses on creating advanced biopharmaceutical solutions. Katsuhiro Shinjo serves as both the CEO and founder, having previously founded other ventures in the biopharmaceutical sector.MabGenesis specializes in the development of advanced biopharmaceutical products, primarily focusing on innovative therapies designed to address unmet medical needs in the fields of oncology and autoimmune diseases. Their core product offerings include monoclonal antibodies and biologics that target specific disease mechanisms, facilitating improved patient outcomes through personalized treatment approaches. These products have been meticulously engineered to engage with specific cellular pathways, effectively altering disease progression and enhancing the efficacy of existing treatment modalities. MabGenesis’s client base includes healthcare institutions, research organizations, and pharmaceutical companies, which utilize their products in clinical settings and research initiatives.The revenue model for MabGenesis is structured around strategic partnerships and direct sales to healthcare providers. The company engages in B2B transactions, collaborating with hospitals and research labs to provide its innovative therapies. These transactions may include licensing agreements for proprietary technologies, enabling partner companies to incorporate MabGenesis's products into their own treatment regimens. Pricing strategies for these products are aligned with market standards for biopharmaceuticals, ensuring competitiveness while reflecting the advanced nature of their offerings.In December 2024, MabGenesis Inc. The company plans to launch several new products in the coming years, targeting specific therapeutic areas within the oncology and autoimmune disease sectors. MabGenesis is also focused on expanding its market presence in Asia and Europe by 2025, leveraging the recent investment to enhance its operational capabilities and broaden its geographic reach.
Who invested in MabGenesis
4 investors across 2 rounds
See all investors in MabGenesis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MabGenesis
Who invested in MabGenesis?
MabGenesis has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MabGenesis raised?
MabGenesis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did MabGenesis last raise money?
MabGenesis's most recent round on record is a Seed, in Jun 2020.
What does MabGenesis do?
Based in Japan, MabGenesis Inc.
Where is MabGenesis headquartered?
MabGenesis is headquartered in Yokohama-shi, Japan.
Which VCs invest in companies like MabGenesis?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at MabGenesis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like MabGenesis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.